Cosmo Pharmaceuticals N.V. (SWX:COPN)
115.80
+1.20 (1.05%)
At close: Jan 30, 2026
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 332 employees as of June 30, 2025. The number of employees increased by 10 or 3.17% since the number was reported on December 31, 2024.
Employees
332
Change
10
Growth
3.17%
Revenue / Employee
512.76K CHF
Profits / Employee
168.77K CHF
Market Cap
1.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 332 | 10 | 3.17% |
| Dec 31, 2024 | 322 | -3 | -0.98% |
| Dec 31, 2023 | 325 | 30 | 10.17% |
| Dec 31, 2022 | 295 | 5 | 1.72% |
| Dec 31, 2021 | 290 | 25 | 9.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 19,299 |
| Aevis Victoria | 4,731 |
| Tecan Group AG | 3,000 |
| Medacta Group | 2,041 |
| SKAN Group AG | 1,504 |
| PolyPeptide Group AG | 1,400 |
Cosmo Pharmaceuticals News
- 19 days ago - Cosmo Pharmaceuticals Posts EUR 104 Mln Revenue, Midpoint Of 2025 Guidance Range - Nasdaq
- 7 weeks ago - Is this the end of baldness? This stock jumps 50% on breakthrough - Finbold
- 2 months ago - Cosmo Pharmaceuticals (CMOPF) Stock Soars on Promising Hair Loss Treatment Results - GuruFocus
- 2 months ago - EU Grants Marketing Authorization For Winlevi Cream - Nasdaq
- 3 months ago - EU Approves Cosmo Pharma' Winlevi For Acne Treatment In Adults And Adolescents - Nasdaq
- 5 months ago - Winlevi Acne Cream Secures EU Drug Panel Support in Reversal for Cosmo - Financial Post
- 10 months ago - Cosmo Pharmaceuticals ernennt neuen Chief Legal Counsel - Cash
- 11 months ago - Cosmo Pharmaceuticals reports FY results - Seeking Alpha